Clinical Trial Update: ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ACTHAR for acute treatment in rheumatoid arthritis patients with inadequate response to methotrexate was terminated after results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2021-01-15